BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1658620)

  • 1. A novel protein factor is required for use of distal alternative 5' splice sites in vitro.
    Harper JE; Manley JL
    Mol Cell Biol; 1991 Dec; 11(12):5945-53. PubMed ID: 1658620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple activities of the human splicing factor ASF.
    Harper JE; Manley JL
    Gene Expr; 1992; 2(1):19-29. PubMed ID: 1535526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro splicing of adenovirus E1A transcripts: characterization of novel reactions and of multiple branch points abnormally far from the 3' splice site.
    Gattoni R; Schmitt P; Stevenin J
    Nucleic Acids Res; 1988 Mar; 16(6):2389-409. PubMed ID: 2966339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing of E1A transcripts of adenovirus requires appropriate ionic conditions in vitro.
    Schmitt P; Gattoni R; Keohavong P; Stévenin J
    Cell; 1987 Jul; 50(1):31-9. PubMed ID: 2954651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing of adenovirus 2 early region 1A mRNAs is non-sequential.
    Svensson C; Pettersson U; Akusjärvi G
    J Mol Biol; 1983 Apr; 165(3):475-95. PubMed ID: 6302292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential block of U small nuclear ribonucleoprotein particle interactions during in vitro splicing of adenovirus E1A transcripts containing abnormally short introns.
    Himmelspach M; Gattoni R; Gerst C; Chebli K; Stévenin J
    Mol Cell Biol; 1991 Mar; 11(3):1258-69. PubMed ID: 1825346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of alternative splicing of adenoviral E1A transcripts: factors involved in the early-to-late transition.
    Gattoni R; Chebli K; Himmelspach M; Stévenin J
    Genes Dev; 1991 Oct; 5(10):1847-58. PubMed ID: 1833268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing of the adenovirus-2 E1A 13S mRNA requires a minimal intron length and specific intron signals.
    Ulfendahl PJ; Pettersson U; Akusjärvi G
    Nucleic Acids Res; 1985 Sep; 13(17):6299-315. PubMed ID: 2995926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of adenovirus E1B mRNA synthesis by a shift in the activities of RNA splice sites.
    Montell C; Fisher EF; Caruthers MH; Berk AJ
    Mol Cell Biol; 1984 May; 4(5):966-72. PubMed ID: 6727875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A U1 small nuclear ribonucleoprotein particle with altered specificity induces alternative splicing of an adenovirus E1A mRNA precursor.
    Yuo CY; Weiner AM
    Mol Cell Biol; 1989 Aug; 9(8):3429-37. PubMed ID: 2477685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins.
    Stephens C; Harlow E
    EMBO J; 1987 Jul; 6(7):2027-35. PubMed ID: 2958276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A compensatory base change in U1 snRNA suppresses a 5' splice site mutation.
    Zhuang Y; Weiner AM
    Cell; 1986 Sep; 46(6):827-35. PubMed ID: 3757028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Titration of serine/arginine (SR) splicing factors during adenoviral infection modulates E1A pre-mRNA alternative splicing.
    Himmelspach M; Cavaloc Y; Chebli K; Stévenin J; Gattoni R
    RNA; 1995 Oct; 1(8):794-806. PubMed ID: 7493325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lytic and transforming functions of individual products of the adenovirus E1A gene.
    Moran E; Grodzicker T; Roberts RJ; Mathews MB; Zerler B
    J Virol; 1986 Mar; 57(3):765-75. PubMed ID: 2936898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.
    Bourgeois CF; Popielarz M; Hildwein G; Stevenin J
    Mol Cell Biol; 1999 Nov; 19(11):7347-56. PubMed ID: 10523623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of SV40 early pre-mRNA in vitro.
    van Santen VL; Spritz RA
    Nucleic Acids Res; 1986 Dec; 14(24):9911-26. PubMed ID: 3027668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the branch site/3'-splice site region in adenovirus-2 E1A pre-mRNA alternative splicing: evidence for 5'- and 3'-splice site co-operation.
    Ulfendahl PJ; Kreivi JP; Akusjärvi G
    Nucleic Acids Res; 1989 Feb; 17(3):925-38. PubMed ID: 2922277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of RNase-A-resistant regions of adenovirus 2 major late precursor-mRNA in splicing extracts reveals an ordered interaction of nuclear components with the substrate RNA.
    Krämer A
    J Mol Biol; 1987 Aug; 196(3):559-73. PubMed ID: 3681967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro.
    Ge H; Manley JL
    Cell; 1990 Jul; 62(1):25-34. PubMed ID: 2163768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.